Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

AbbVie (ABBV) Short Interest Ratio & Short Volume

AbbVie logo
$204.78 +3.31 (+1.64%)
Closing price 08/14/2025 03:59 PM Eastern
Extended Trading
$204.70 -0.08 (-0.04%)
As of 06:18 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

AbbVie Short Interest Data

AbbVie (ABBV) has a short interest of 15.13 million shares, representing 0.86% of the float (the number of shares available for trading by the public). This marks a -3.07% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.4, indicating that it would take 2.4 days of the average trading volume of 4.95 million shares to cover all short positions.

Current Short Interest
15,130,000 shares
Previous Short Interest
15,610,000 shares
Change Vs. Previous Month
-3.07%
Dollar Volume Sold Short
$2.86 billion
Short Interest Ratio
2.4 Days to Cover
Last Record Date
July 31, 2025
Outstanding Shares
1,766,560,000 shares
Float Size
1,760,000,000 shares
Short Percent of Float
0.86%
Today's Trading Volume
4,634,275 shares
Average Trading Volume
4,949,353 shares
Today's Volume Vs. Average
94%
Short Selling AbbVie?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for AbbVie and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ABBV Short Interest Over Time

ABBV Days to Cover Over Time

ABBV Percentage of Float Shorted Over Time

AbbVie Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/202515,130,000 shares $2.86 billion -3.1%0.9%2.4 $189.02
7/15/202515,610,000 shares $2.91 billion -2.1%0.9%2.4 $186.56
6/30/202515,950,000 shares $2.96 billion +8.5%0.9%2.1 $185.80
6/15/202514,700,000 shares $2.80 billion -7.5%0.8%2 $190.67
5/31/202515,890,000 shares $2.95 billion -20.3%0.9%2.1 $185.53
5/15/202519,930,000 shares $3.62 billion +0.7%1.1%2.5 $181.52
4/30/202519,800,000 shares $3.86 billion +17.6%N/A2.6 $195.15
4/15/202516,840,000 shares $2.98 billion -1.8%1.0%2.3 $176.84
3/31/202517,140,000 shares $3.60 billion -13.0%1.0%2.4 $209.83
3/15/202519,700,000 shares $4.17 billion +6.4%1.1%3.1 $211.90
2/28/202518,510,000 shares $3.87 billion -5.7%1.1%3 $209.07
2/15/202519,620,000 shares $3.79 billion +3.7%1.1%3.3 $193.00
1/31/202518,930,000 shares $3.48 billion +4.2%1.1%2.9 $183.90
1/15/202518,160,000 shares $3.11 billion +6.8%N/A2.8 $171.32
12/31/202417,000,000 shares $3.02 billion -8.3%N/A2.7 $177.70
12/15/202418,530,000 shares $3.21 billion -4.1%N/A3 $173.37
11/30/202419,320,000 shares $3.53 billion -4.2%N/A3.3 $182.93
11/15/202420,170,000 shares $3.33 billion +11.3%N/A3.5 $164.91
10/31/202418,130,000 shares $3.70 billion +12.1%N/A3.7 $203.87
10/15/202416,180,000 shares $3.10 billion +8.9%0.9%3.4 $191.86
9/30/202414,860,000 shares $2.93 billion -16.5%0.8%3.2 $197.48
9/15/202417,790,000 shares $3.45 billion -8.7%1.0%3.5 $194.21
8/31/202419,490,000 shares $3.83 billion -3.5%1.1%3.7 $196.31
8/15/202420,190,000 shares $3.90 billion +15.2%1.2%3.7 $193.40
7/31/202417,530,000 shares $3.25 billion +7.0%1.0%3.2 $185.32
7/15/202416,380,000 shares $2.75 billion +1.0%0.9%3 $168.03
6/30/202416,220,000 shares $2.78 billion +6.4%0.9%3 $171.52
6/15/202415,250,000 shares $2.57 billion -7.5%0.9%2.9 $168.59
5/31/202416,490,000 shares $2.66 billion +3.5%0.9%2.9 $161.19
5/15/202415,930,000 shares $2.61 billion +10.0%0.9%2.9 $163.78
4/30/202414,480,000 shares $2.36 billion +6.9%0.8%2.6 $162.69
4/15/202413,540,000 shares $2.19 billion +3.2%N/A2.4 $161.67
3/31/202413,120,000 shares $2.39 billion -10.7%N/A2.3 $182.10
3/15/202414,690,000 shares $2.61 billion +2.9%0.8%2.7 $177.88
2/29/202414,270,000 shares $2.51 billion -3.3%0.8%2.6 $175.61
2/15/202414,750,000 shares $2.60 billion +7.5%0.8%2.8 $176.61
1/31/202413,720,000 shares $2.26 billion +1.2%0.8%2.5 $164.36
1/15/202413,560,000 shares $2.20 billion +12.3%0.8%2.4 $162.40
12/31/202312,080,000 shares $1.87 billion -11.8%0.7%2.2 $154.97
12/15/202313,690,000 shares $2.11 billion +23.0%0.8%2.6 $154.07
The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)

Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.

This little-known company holds nearly 100 patents and trades for around $7
11/30/202311,130,000 shares $1.58 billion -0.2%0.6%2.2 $142.35
11/15/202311,150,000 shares $1.53 billion -15.7%0.6%2.4 $137.61
10/31/202313,230,000 shares $1.87 billion +15.3%0.8%3 $141.18
10/15/202311,470,000 shares $1.70 billion -6.8%0.7%2.6 $147.96
9/30/202312,310,000 shares $1.83 billion +3.2%0.7%2.7 $149.06
9/15/202311,930,000 shares $1.81 billion -4.2%0.7%2.4 $152.09
8/31/202312,450,000 shares $1.83 billion -6.1%0.7%2.4 $146.96
8/15/202313,260,000 shares $2.02 billion +15.9%0.8%2.3 $152.12
7/31/202311,440,000 shares $1.71 billion +20.3%0.7%2 $149.58
7/15/20239,510,000 shares $1.29 billion -8.2%0.5%1.6 $136.01
6/30/202310,360,000 shares $1.40 billion -8.4%0.6%1.8 $134.72
6/15/202311,310,000 shares $1.54 billion -0.6%0.6%2 $135.89
5/31/202311,380,000 shares $1.57 billion -4.9%0.7%1.9 $137.96
5/15/202311,970,000 shares $1.75 billion -23.5%0.7%2.1 $146.59
4/30/202315,650,000 shares $2.37 billion +3.4%0.9%2.6 $151.12
4/15/202315,140,000 shares $2.45 billion -7.0%N/A2.6 $161.59
3/31/202316,280,000 shares $2.59 billion +16.0%N/A2.6 $159.37
3/15/202314,040,000 shares $2.16 billion +10.6%N/A2.3 $154.06
2/28/202312,700,000 shares $1.95 billion +8.5%N/A2.3 $153.90
2/15/202311,710,000 shares $1.77 billion +13.7%N/A2.1 $151.06
1/31/202310,300,000 shares $1.52 billion -13.9%N/A1.8 $147.75
1/15/202311,960,000 shares $1.84 billion -7.5%N/A2.2 $153.60
12/30/202212,930,000 shares $2.09 billion -4.8%N/A2.5 $161.61
12/15/202213,580,000 shares $2.21 billion -0.6%N/A2.4 $163.10
11/30/202213,660,000 shares $2.20 billion +5.8%N/A2.4 $161.18
11/15/202212,910,000 shares $1.98 billion -6.5%N/A2.3 $153.04
10/31/202213,800,000 shares $2.02 billion -1.4%N/A2.6 $146.40
10/15/202214,000,000 shares $2.00 billion +5.3%N/A2.6 $142.94
9/30/202213,290,000 shares $1.78 billion +2.6%N/A2.4 $134.21
9/15/202212,950,000 shares $1.85 billion +13.8%N/A2.4 $142.51
8/31/202211,380,000 shares $1.53 billion -12.5%N/A2.1 $134.46
8/15/202213,010,000 shares $1.85 billion -6.1%N/A2.2 $142.29
7/31/202213,850,000 shares $1.99 billion -1.3%0.8%2.2 $143.51
7/15/202214,030,000 shares $2.16 billion -2.7%0.8%2.1 $153.62
6/30/202214,420,000 shares $2.21 billion +6.7%1.0%2 $153.16
6/15/202213,520,000 shares $1.87 billion +6.0%0.9%1.9 $138.09
5/31/202212,750,000 shares $1.88 billion -10.4%0.7%1.8 $147.37
5/15/202214,230,000 shares $2.18 billion +8.2%0.8%1.9 $153.50
4/30/202213,150,000 shares $1.93 billion +9.0%0.8%1.7 $146.88
4/15/202212,070,000 shares $1.96 billion -10.2%0.7%1.5 $162.31
3/31/202213,440,000 shares $2.18 billion -9.7%0.8%1.7 $162.11
3/15/202214,890,000 shares $2.32 billion -6.9%N/A1.9 $155.88
2/28/202215,990,000 shares $2.36 billion +3.9%N/A2 $147.77
2/15/202215,390,000 shares $2.23 billion -4.7%N/A2 $144.76
1/31/202216,150,000 shares $2.21 billion +12.7%0.9%2.3 $136.89
1/15/202214,330,000 shares $1.95 billion -13.7%0.8%2.2 $135.87
12/31/202116,610,000 shares $2.25 billion +7.6%0.9%2.7 $135.40
12/15/202115,440,000 shares $2.01 billion +9.4%0.9%2.5 $130.23
11/30/202114,120,000 shares $1.63 billion +0.2%N/A2.3 $115.28
11/15/202114,090,000 shares $1.65 billion +3.5%0.8%2 $116.84
The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)

Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.

This little-known company holds nearly 100 patents and trades for around $7
10/29/202113,620,000 shares $1.56 billion +18.5%0.8%1.9 $114.67
10/15/202111,490,000 shares $1.26 billion -16.0%0.7%1.6 $109.33
9/30/202113,670,000 shares $1.47 billion +5.2%0.8%1.9 $107.87
9/15/202112,990,000 shares $1.40 billion -4.1%0.7%1.9 $107.77
8/31/202113,550,000 shares $1.64 billion +3.5%0.8%2 $120.78
8/13/202113,090,000 shares $1.52 billion -9.4%0.7%2.2 $116.48
7/30/202114,450,000 shares $1.68 billion -1.4%0.8%2.3 $116.30
7/15/202114,660,000 shares $1.72 billion +6.5%0.8%2.3 $117.18
6/30/202113,770,000 shares $1.55 billion +3.2%0.8%2.2 $112.64
6/15/202113,340,000 shares $1.55 billion -9.6%0.8%2 $115.83
5/28/202114,760,000 shares $1.67 billion -3.4%0.8%2.1 $113.20
5/14/202115,280,000 shares $1.78 billion +2.6%N/A2.2 $116.60
4/30/202114,890,000 shares $1.65 billion -20.4%N/A2.2 $110.89
4/15/202118,710,000 shares $1.98 billion +11.4%N/A2.6 $105.90
3/31/202116,800,000 shares $1.79 billion +3.7%N/A2.3 $106.79
3/15/202116,200,000 shares $1.75 billion +5.0%N/A2.2 $108.22
2/26/202115,430,000 shares $1.66 billion +8.1%N/A2.2 $107.33
2/12/202114,280,000 shares $1.48 billion -4.0%N/A1.9 $103.75
1/29/202114,870,000 shares $1.55 billion +18.1%N/A1.9 $104.21
1/15/202112,590,000 shares $1.41 billion -5.6%N/A1.5 $111.63
12/31/202013,330,000 shares $1.40 billion -3.8%N/A1.6 $105.27
12/15/202013,850,000 shares $1.44 billion +4.4%N/A1.7 $104.20
11/30/202013,270,000 shares $1.39 billion -5.2%N/A1.6 $104.89
11/15/202014,000,000 shares $1.39 billion +9.0%N/A1.7 $99.04
10/30/202012,840,000 shares $1.04 billion +20.7%N/A1.6 $80.67
10/15/202010,640,000 shares $915.78 million -17.8%N/A1.5 $86.07
9/30/202012,940,000 shares $1.13 billion -2.6%N/A1.9 $87.59
9/15/202013,280,000 shares $1.21 billion +9.2%N/A1.9 $90.91
8/31/202012,160,000 shares $1.16 billion -2.0%N/A1.7 $95.77

ABBV Short Interest - Frequently Asked Questions

What is AbbVie's current short interest?

Short interest is the volume of AbbVie shares that have been sold short but have not yet been covered or closed out. As of July 31st, traders have sold 15,130,000 shares of ABBV short. 0.86% of AbbVie's shares are currently sold short. Learn More on AbbVie's current short interest.

What is a good short interest ratio for AbbVie?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABBV shares currently have a short interest ratio of 2.0. Learn More on AbbVie's short interest ratio.

Which institutional investors are shorting AbbVie?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of AbbVie: Jane Street Group LLC, Volterra Technologies LP, Squarepoint Ops LLC, Kopernik Global Investors LLC, Qube Research & Technologies Ltd, Maven Securities LTD, Bank of Nova Scotia, Bosun Asset Management LLC, Capula Management Ltd, Walleye Capital LLC, Walleye Trading LLC, Lido Advisors LLC, Delta Accumulation LLC, Hsbc Holdings PLC, Capital Fund Management S.A., Sumitomo Mitsui Financial Group Inc., Eisler Capital Management Ltd., JPMorgan Chase & Co., Citigroup Inc., Creative Planning, SG Americas Securities LLC, Calamos Advisors LLC, Garda Capital Partners LP, Marathon Trading Investment Management LLC, Mirae Asset Securities USA Inc., Simplex Trading LLC, Wolverine Asset Management LLC, Portman Square Capital LLP, VELA Investment Management LLC, Allianz Asset Management GmbH, Twin Tree Management LP, ADAPT Investment Managers SA, IMC Chicago LLC, CenterStar Asset Management LLC, Quaker Wealth Management LLC, Jane Street Group LLC, Goldman Sachs Group Inc., Parallax Volatility Advisers L.P., Millennium Management LLC, and Bosun Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for AbbVie?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.86% of AbbVie's floating shares are currently sold short.

Is AbbVie's short interest increasing or decreasing?

AbbVie saw a drop in short interest during the month of July. As of July 31st, there was short interest totaling 15,130,000 shares, a drop of 3.1% from the previous total of 15,610,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is AbbVie's float size?

AbbVie currently has issued a total of 1,766,560,000 shares. Some of AbbVie's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. AbbVie currently has a public float of 1,760,000,000 shares.

How does AbbVie's short interest compare to its competitors?

0.86% of AbbVie's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to AbbVie: Amgen Inc. (2.33%), Gilead Sciences, Inc. (1.61%), Moderna, Inc. (18.29%), Abbott Laboratories (1.06%), Bristol Myers Squibb Company (1.52%), Johnson & Johnson (0.71%), Eli Lilly and Company (0.84%), Merck & Co., Inc. (1.04%), Pfizer Inc. (1.90%), Zoetis Inc. (1.55%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), MicroStrategy Incorporated ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks.

What does it mean to sell short AbbVie stock?

Short selling ABBV is an investing strategy that aims to generate trading profit from AbbVie as its price is falling. ABBV shares are trading up $3.31 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against AbbVie?

A short squeeze for AbbVie occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ABBV, which in turn drives the price of the stock up even further.

How often is AbbVie's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABBV, twice per month. The most recent reporting period available is July, 31 2025.



Related Companies
Short Interest Tools

This page (NYSE:ABBV) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsored
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump c...
Weiss Ratings | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsored
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsored
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsored
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsored